Richman Eric I's Form 4 filing
Gain Therapeutics, Inc. (GANX) · filed May 23, 2022
- Accession no.
- 0001415889-22-005501
- Filed
- May 23, 2022
- Trade date
- May 19-20, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $37.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Richman Eric ICIK 0001313876 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | Common stock | PPurchaseAcquired | +4,000 | $2.71 | +$10,840 | 205,991 | Direct | |
| May 20, 2022 | Common Stock | PPurchaseAcquired | +9,256 | $2.83 | +$26,194.48 | 215,247 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.